Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
National Presto Industries
NPK
$784M
| $1.13M | ﹤0.01% |
11,100
| – | – |
|
2302
Phibro Animal Health
PAHC
$1.67B
| $1.13M | ﹤0.01% |
46,400
+1,200
| +3% | +$29.3K |
|
2303
ARKO Corp
ARKO
$563M
| $1.13M | ﹤0.01% |
113,461
+48,400
| +74% | +$481K |
|
2304
Independent Bank Corp
IBCP
$661M
| $1.13M | ﹤0.01% |
47,700
| – | – |
|
|
PRVB
2305
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.13M | ﹤0.01% |
107,500
+18,400
| +21% | +$193K |
|
2306
MBIA
MBI
$374M
| $1.13M | ﹤0.01% |
117,100
-6,900
| -6% | -$66.4K |
|
2307
HCI Group
HCI
$2.31B
| $1.12M | ﹤0.01% |
14,600
| – | – |
|
2308
TherapeuticsMD
TXMD
$12.7M
| $1.12M | ﹤0.01% |
16,744
+5,600
| +50% | +$375K |
|
2309
GoHealth
GOCO
$75.9M
| $1.11M | ﹤0.01% |
6,347
| – | – |
|
2310
Geron
GERN
$823M
| $1.11M | ﹤0.01% |
703,400
| – | – |
|
2311
Forrester Research
FORR
$188M
| $1.11M | ﹤0.01% |
26,050
+500
| +2% | +$21.2K |
|
|
AD
2312
Array Digital Infrastructure, Inc.
AD
$4.41B
| $1.11M | ﹤0.01% |
30,300
| – | – |
|
2313
A10 Networks
ATEN
$1.26B
| $1.1M | ﹤0.01% |
114,500
| – | – |
|
|
DCBO
2314
Docebo
DCBO
$863M
| $1.1M | ﹤0.01% |
25,600
| – | – |
|
2315
Bank of Marin Bancorp
BMRC
$399M
| $1.1M | ﹤0.01% |
28,000
+700
| +3% | +$27.4K |
|
2316
Nano X Imaging
NNOX
$242M
| $1.09M | ﹤0.01% |
26,300
| – | – |
|
2317
Diamond Hill
DHIL
$387M
| $1.09M | ﹤0.01% |
6,954
| – | – |
|
2318
MidWestOne Financial Group
MOFG
$609M
| $1.08M | ﹤0.01% |
35,000
+700
| +2% | +$21.7K |
|
2319
First Community Bankshares
FCBC
$684M
| $1.08M | ﹤0.01% |
36,079
| – | – |
|
|
BFX
2320
DELISTED
BowFlex Inc.
BFX
| $1.08M | ﹤0.01% |
69,200
+1,400
| +2% | +$21.9K |
|
2321
Waterstone Financial
WSBF
$275M
| $1.08M | ﹤0.01% |
52,900
| – | – |
|
2322
Omega Flex
OFLX
$341M
| $1.07M | ﹤0.01% |
6,800
| – | – |
|
|
SPPI
2323
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.07M | ﹤0.01% |
329,500
| – | – |
|
2324
Willdan Group
WLDN
$1.48B
| $1.06M | ﹤0.01% |
25,900
| – | – |
|
2325
Akebia Therapeutics
AKBA
$777M
| $1.06M | ﹤0.01% |
313,785
+9,700
| +3% | +$32.8K |
|